2.605
price down icon2.43%   -0.065
 
loading
Schlusskurs vom Vortag:
$2.67
Offen:
$2.66
24-Stunden-Volumen:
689.09K
Relative Volume:
1.09
Marktkapitalisierung:
$213.57M
Einnahmen:
$153.73M
Nettoeinkommen (Verlust:
$-106.79M
KGV:
-1.0547
EPS:
-2.47
Netto-Cashflow:
$-115.93M
1W Leistung:
-24.49%
1M Leistung:
-28.43%
6M Leistung:
-42.62%
1J Leistung:
-3.16%
1-Tages-Spanne:
Value
$2.52
$2.7677
1-Wochen-Bereich:
Value
$2.52
$3.46
52-Wochen-Spanne:
Value
$2.13
$6.13

Sutro Biopharma Inc Stock (STRO) Company Profile

Name
Firmenname
Sutro Biopharma Inc
Name
Telefon
650-392-8412
Name
Adresse
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Name
Mitarbeiter
306
Name
Twitter
@SutroBio
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
STRO's Discussions on Twitter

Vergleichen Sie STRO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
STRO 2.601 213.57M 153.73M -106.79M -115.93M -2.47
VRTX 450.60 115.43B 10.63B -479.80M -1.35B 13.33
REGN 747.31 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 591.22 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.28 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.27 24.89B 3.30B -501.07M 1.03B 11.54

Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-03-21 Herabstufung Wells Fargo Overweight → Equal Weight
2022-08-18 Fortgesetzt Wells Fargo Overweight
2021-06-18 Eingeleitet H.C. Wainwright Buy
2020-12-03 Eingeleitet Stifel Buy
2020-09-02 Eingeleitet Jefferies Buy
2020-07-16 Eingeleitet Wells Fargo Overweight
2020-01-13 Eingeleitet SunTrust Buy
2019-10-07 Eingeleitet BTIG Research Buy
2019-07-18 Eingeleitet Deutsche Bank Buy
2019-04-29 Eingeleitet H.C. Wainwright Buy
2018-10-22 Eingeleitet JMP Securities Mkt Outperform
2018-10-22 Eingeleitet Piper Jaffray Overweight
2018-10-22 Eingeleitet Wedbush Outperform
Alle ansehen

Sutro Biopharma Inc Aktie (STRO) Neueste Nachrichten

pulisher
03:01 AM

Sutro Biopharma Advances Pipeline Amid Financial Losses - MSN

03:01 AM
pulisher
01:57 AM

HC Wainwright Estimates Sutro Biopharma Q2 Earnings - Defense World

01:57 AM
pulisher
01:45 AM

HC Wainwright Raises Earnings Estimates for Sutro Biopharma - Defense World

01:45 AM
pulisher
Nov 20, 2024

Brokers Set Expectations for Sutro Biopharma FY2024 Earnings - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

HC Wainwright Reaffirms Buy Rating for Sutro Biopharma (NASDAQ:STRO) - Defense World

Nov 20, 2024
pulisher
Nov 20, 2024

Sutro Biopharma (STRO) Upgraded to Buy: Here's What You Should Know - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Analysts Set Expectations for Sutro Biopharma Q2 Earnings - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Sutro Biopharma's (STRO) Buy Rating Reiterated at HC Wainwright - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

A Glimpse Into The Expert Outlook On Sutro Biopharma Through 5 Analysts - Benzinga

Nov 18, 2024
pulisher
Nov 18, 2024

Sutro Biopharma FY2024 EPS Forecast Increased by Wedbush - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

Sutro Biopharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 15, 2024
pulisher
Nov 14, 2024

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Baillie Gifford & Co. - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 14, 2024
pulisher
Nov 13, 2024

Sutro Biopharma earnings beat by $0.14, revenue fell short of estimates - Investing.com UK

Nov 13, 2024
pulisher
Nov 13, 2024

Sutro Biopharma Inc (STRO) Q3 2024 Earnings: Revenue Misses Esti - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Sutro Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

Sutro Biopharma Reports 56% Response Rate in Cancer Trial, Plans 3 New Drug Applications | STRO Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 12, 2024

BioSpace Announces 2025 Best Places to Work in Biopharma - BioSpace

Nov 12, 2024
pulisher
Nov 09, 2024

Caribou Biosciences (NASDAQ:CRBU) vs. Sutro Biopharma (NASDAQ:STRO) Financial Analysis - Defense World

Nov 09, 2024
pulisher
Nov 07, 2024

Sutro Biopharma (NASDAQ:STRO) shareholders are up 16% this past week, but still in the red over the last three years - Simply Wall St

Nov 07, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Sutro Biopharma Inc - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

Sutro Biopharma Demonstrates Meaningful ADC Innovation with Five Presentations at the 15th Annual World ADC Conference - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

Sutro Biopharma begins trial of acute myeloid leukaemia treatment in children - Clinical Trials Arena

Nov 04, 2024
pulisher
Nov 03, 2024

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Rating of “Buy” from Brokerages - Defense World

Nov 03, 2024
pulisher
Nov 03, 2024

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $12.13 Average PT from Brokerages - MarketBeat

Nov 03, 2024
pulisher
Nov 01, 2024

Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML - The Manila Times

Nov 01, 2024
pulisher
Oct 24, 2024

Sutro Biopharma's SWOT analysis: stock poised for growth amid clinical progress - Investing.com

Oct 24, 2024
pulisher
Oct 21, 2024

The Manufacturers Life Insurance Company Buys 7,082 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Oct 21, 2024
pulisher
Oct 20, 2024

Sutro Biopharma (NASDAQ:STRO) shareholders have endured a 80% loss from investing in the stock three years ago - Yahoo Finance

Oct 20, 2024
pulisher
Oct 17, 2024

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Cubist Systematic Strategies LLC - MarketBeat

Oct 17, 2024
pulisher
Oct 15, 2024

Sutro Biopharma: Post ESMO Selloff, Does Their Strategy In FRα Remain Viable? - Seeking Alpha

Oct 15, 2024
pulisher
Oct 14, 2024

Sutro Biopharma Inc Inc. (STRO) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle

Oct 14, 2024
pulisher
Oct 13, 2024

Algert Global LLC Reduces Stake in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

AQR Capital Management LLC Boosts Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

AQR Capital Management LLC Buys 247,694 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - MarketBeat

Oct 13, 2024
pulisher
Oct 13, 2024

HC Wainwright Reiterates “Buy” Rating for Sutro Biopharma (NASDAQ:STRO) - Defense World

Oct 13, 2024
pulisher
Oct 12, 2024

Sutro Biopharma (NASDAQ:STRO) & Palisade Bio (NASDAQ:PALI) Head-To-Head Contrast - Defense World

Oct 12, 2024
pulisher
Oct 11, 2024

Piper Sandler sustains Overweight rating on Sutro Biopharma shares By Investing.com - Investing.com Canada

Oct 11, 2024
pulisher
Oct 11, 2024

Sutro Biopharma retains stock target with Buy rating on key advancements - Investing.com Canada

Oct 11, 2024
pulisher
Oct 11, 2024

Peeling Back The Layers: Exploring Sutro Biopharma Through Analyst Insights - Benzinga

Oct 11, 2024
pulisher
Oct 11, 2024

Sutro Biopharma (NASDAQ:STRO) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Revenues Working Against Sutro Biopharma, Inc.'s (NASDAQ:STRO) Share Price Following 25% Dive - Simply Wall St

Oct 11, 2024
pulisher
Oct 11, 2024

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Dimensional Fund Advisors LP - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Sutro Biopharma Highlights Next-Generation ADC Innovation and Near-term Pipeline at Research Forum - The Manila Times

Oct 11, 2024
pulisher
Oct 11, 2024

After-Market Gains For Sutro Biopharma (STRO) Following An Investor Webcast - Stocks Telegraph

Oct 11, 2024
pulisher
Oct 09, 2024

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $12.13 Average Price Target from Analysts - MarketBeat

Oct 09, 2024
pulisher
Oct 09, 2024

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Bought by ProShare Advisors LLC - Defense World

Oct 09, 2024
pulisher
Oct 08, 2024

Cubist Systematic Strategies LLC Trims Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Oct 08, 2024
pulisher
Oct 08, 2024

Millennium Management LLC Has $12.78 Million Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO) - MarketBeat

Oct 08, 2024
pulisher
Oct 07, 2024

It would be worthwhile to take a closer look at Sutro Biopharma Inc (STRO) - US Post News

Oct 07, 2024

Finanzdaten der Sutro Biopharma Inc-Aktie (STRO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Sutro Biopharma Inc-Aktie (STRO) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Chung Jane
PRESIDENT AND COO
Aug 09 '24
Option Exercise
0.00
18,750
0
60,951
Srinivasan Venkatesh
CHIEF TECH OP OFFICER
May 01 '24
Option Exercise
0.00
2,500
0
32,622
Srinivasan Venkatesh
CHIEF TECH OP OFFICER
Apr 11 '24
Option Exercise
0.00
21,250
0
37,704
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
Mar 05 '24
Option Exercise
0.00
8,750
0
76,060
NEWELL WILLIAM J
CEO
Mar 05 '24
Option Exercise
0.00
18,750
0
226,893
ALBINI EDWARD C
CFO AND SECRETARY
Mar 05 '24
Option Exercise
0.00
8,750
0
109,843
NEWELL WILLIAM J
CEO
Mar 04 '24
Option Exercise
0.00
31,125
0
219,248
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
Mar 04 '24
Option Exercise
0.00
9,125
0
71,049
Chung Jane
PRESIDENT AND COO
Mar 04 '24
Option Exercise
0.00
7,875
0
44,410
ALBINI EDWARD C
CFO AND SECRETARY
Mar 04 '24
Option Exercise
0.00
9,125
0
104,565
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):